Navigation Links
Needle free future for diabetics

A way which draws substances into and out of the skin without pricking it makes for easier blood testing in diabetes. Iontophoresis is a relatively new method which uses the application of an electric field// to draw molecules into and out of the skin's barrier without the need for an injection. It could mean taking blood samples without a syringe, and administering drugs without an injection.

Researchers at the University of Texas, tried to show just what can be done for people with diabetes using iontophoresis. There's already a monitoring device called 'Glucowatch' which extracts glucose through the skin using iontophoresis. This allows the constant monitoring of blood glucose that's necessary to keep diabetes in check. But at present the device has to be checked by also taking a blood sample, which limits its appeal.

The Texas team is now applying iontophoresis to take a sodium sample through the skin to replace this blood test. The result of this will be a needle-free glucose monitoring. The method is still in its early stages, but it's already looking extremely promising. Meanwhile, keep watching this space - for iontophoresis is also being developed as a drug delivery system.


'"/>




Page: 1

Related medicine news :

1. Nurses In Ontario demands Safe Disposable Needles
2. Fat Patients Require Longer Needles
3. Needle-Free Injection System Ideal for Pandemic Outbreaks
4. Girlie Needle And Thread help Japanese Men to De-Stress
5. AIIMS Counsel Claims Cancer Patient Got HIV Through Needle
6. PowderMed Announces Needle-Less Flu Vaccine
7. Needles Given To Drug Addicts Go Missing In Scotland
8. Longer Needles Best for Infant Immunisation
9. Novel Way to Overcome Needle Phobia
10. Scottish Prisons May Get Needle Exchange Programs
11. Eighty Children Die Of Aids Due To Tainted Blood, Dirty Needles In Southern Kazakhstan

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Needle free future for diabetics

(Date:11/28/2009)... variation believed to affect circadian rhythm,...-- New research suggests that an internal body clo... development of bipolar disorder in children. ,...genetic makeup of 152 children with bipolar disord...d swings, and 140 children without the disorder. T...
(Date:11/27/2009)...AS, Nov. 27 Considered ... only 25 years ago, solid organ transplantation is...the extraordinary men and women who gathered at th...rs came together from medical centers around the w...egional Transplant Institute (BRTI), one of the pi...
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...N FRANCISCO, Jan. 12 Within health care, dermatol...g quality care to their,patients. , The Dermat...logy,professionals the most up-to-date evidence-ba...nual conference slated for March,4-7 at the Hilton...
... , HOUSTON, Jan. 12 Cyberonics, Inc. (Nasdaq: ...., joined Cyberonics as Vice President, Research a.... Morris will lead all of the company,s developmen...olina, where he has served as Director, Program Ma...
... Miss., Jan. 12 A partnership between Command Spa... one of the country,s leading providers of nursing...f job-specific Spanish language instruction for nu.... Two new courses are available online to nurses n...
..., WASHINGTON, Jan. 12 Sharing Miracles, a 30-minu...e compelling and inspirational stories of real pat... at www.SharingMiracles.com . Sharing Miracles al...nominee and former star of Family Ties Meredith Ba...
...TON, Mass., Jan. 12 Alseres Pharmaceuticals, Inc...ived notice from the NASDAQ Stock Market ("NASDAQ"...he market value of its listed securities has been ... does not comply with NASDAQ Marketplace Rule 4310...
...RK and SAN FRANCISCO, Jan. 12 WeissComm Group, th...t independent communications agency focused exclus...ommunications, an agency focused on helping compan...y companies to cultivate unique brands that resona...
Other Medicine News:Health News:Hop the Trolley for DNA's 27th Annual Conference 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 3Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 4Health News:Nurses: Command Spanish Online's Occupational Spanish Language Course Accepted for Credit by the American Nurses Credentialing Center (ANCC) 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 3Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 4Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 5Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 6Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 2Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 3
(Date:11/25/2009)...Nov. 25 /PRNewswire-Asia-FirstCall/ -- China Sky O...Company") (Nasdaq: CSKI ), a,leading fully integr...ng,over-the-counter drugs in the People,s Republic...y recently passed the Chinese National Institute f...oducts ("ICPBP") examination,for two of its new pr...
(Date:11/25/2009)... Nov. 25 Swissray International, I...graphy ( ddR ) systems, announced today that its o...vestor with a long term view towards growing Swiss...ded all assets and intellectual property, as well ...ess and growth Swissray is now poised to move to t...
(Date:11/25/2009)... Reportlinker.com announces that a ...alogue: ,, Pain Management - Global Trends ...anagement---Global-Trends.html ,, Widespread a...nagement clinics, and the advent of new drugs have...ment market. Healthcare reforms and reimbursement ...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 1Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 2American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 1American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 2American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 3Heartline 28R 29 Fitness Systems Named to Inc 5000 list for Third Consecutive Year 54838 1Heartline 28R 29 Fitness Systems Named to Inc 5000 list for Third Consecutive Year 54838 2
... Sept. 24 Alimera Sciences, Inc., a privately,hel...e research,development and commercialization of pr...ted that after completing its review of safety,and... Data Safety,Monitoring Board (DSMB) has again rec...als for the use of Iluvien(TM) in the treatment of...
... survey shows high prevalence of "bothersome" vagi...non-sexually active postmenopausal, women; resul...enopause Society Meetin... of a,Phase 3 study for Ophena(TM) (ospemifene tab...l atrophy (VVA) in postmenopausal women showed tha...
Other Medicine Technology:DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 2DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4
Laser Contact Lens CGRL
Laser 3 mirror Contact Lens 630 L
...apture and management system that acquires extreme...ICG Angiography images. It interfaces with most cu...om any ophthalmic device with video, digital or TW... Retinal Images from non-mydriatic fundus cameras....
...that replaces the old technology, the automated pr...y bringing virtually unlimited charts to the patie...actitioners finger tips. The STIMULi supports man...sion tests and fixation devices in a simple remote...
Medicine Products: